| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total other income | 3,660 | 4,080 | ||
| Net loss | -42,217 | -43,784 | ||
| Net loss per share, basic (in dollars per share) | -0.49 | -0.51 | ||
| Net loss per share, diluted (in dollars per share) | -0.49 | -0.51 | ||
| Weighted average shares used to compute net loss per share, basic (in shares) | 85,732,221 | 85,497,426 | ||
| Weighted average shares used to compute net loss per share, diluted (in shares) | 85,732,221 | 85,497,426 | ||
Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (OLMA)